Batten disease is a rare genetic disorder that causes waste material to build up in brain cells, leading to progressive neurodegeneration and ultimately cell death. It is a fatal condition, primarily affecting children.
Batten disease is also known as Neuronal Ceroid Lipofuscinoses (NCL), a group of inherited neurodegenerative disorders. It is caused by genetic mutations in one of 13 NCL genes (CLN1 to CLN14, with no CLN9 gene), which disrupt lysosomal function. Lysosomes help recycle waste materials in cells, and when they don’t work properly, toxic waste accumulates, leading to cell damage and death. NCL disease falls under the category of lysosomal storage disorders.
All forms of Batten disease share common symptoms. While all cells have lysosomes, nerve cells are particularly affected, leading to progressive vision loss, seizures, cognitive decline, loss of speech, motor impairment, and premature death. Symptoms can appear in infants, children, or teenagers and worsen over time.
There is currently no cure, and, with the exception of Brineura for CLN2 disease, available treatments manage the symptoms rather than the underlying cause. Ongoing research into gene-based therapies, enzyme replacement, and small-molecule treatments offers hope for future treatment options.
Types of Batten Disease
There are 13 known types of Batten disease, classified based on the affected gene. Symptoms can begin in infancy, childhood, or early teenage years. Each type is named with “CLN” (Ceroid Lipofuscinosis, Neuronal), followed by a number (1-14, excluding CLN9).
Symptoms of Batten Disease
Symptoms vary by type but generally include:
-
Early Signs:
- Vision loss
- Behavioral and personality changes
- Clumsiness and coordination issues
- Seizures
-
Other Symptoms:
- Cognitive decline (thinking and reasoning difficulties)
- Speech and language problems
- Muscle spasms, tremors, and twitches
- Memory loss (dementia)
- Hallucinations and episodes of psychosis
- Sleep disturbances
- Muscle rigidity and weakness
- Heart arrhythmias (in teenagers and young adults)
Children with Batten disease initially develop normally, meeting early milestones like crawling, walking, and talking. However, they eventually lose these abilities as the disease progresses.
Is Batten Disease Inherited?
Yes. Batten disease is an inherited metabolic disorder and usually passed down through an autosomal recessive pattern. This means a child must inherit two copies of the defective gene (one from each biological parent) to develop the disease. Parents who carry one copy of the gene do not show symptoms.
CLN4 has an autosomal dominant pattern of inheritance. This means only one chromosome needs to carry a mutation in the gene to cause disease even though the other gene is fine. Most likely one of the parents is also affected. Inheritance of Batten disease is not dependent on the sex of an individual.
Complications of Batten Disease
Batten disease leads to severe neurological deterioration and early death. Symptoms worsen over time, with vision loss progressing to blindness and muscle weakness leading to paralysis. As waste builds up in cells, organ function declines, ultimately causing organ failure.
Frequently Asked Questions
How common is Batten disease?
Batten disease is an ultra rare condition with a global incidence of 1 in 100,000 per live births. We estimate there are between 110 -150 affected individuals in the UK.
How long do children with Batten disease live?
Each individual’s journey is unique. Life expectancy depends on factors like the specific gene mutation and the age at which symptoms begin.
At what age do symptoms develop?
- Congenital: Symptoms present at birth
- Infantile: Symptoms appear around 6 months
- Late Infantile: Symptoms appear after 18 months
- Juvenile: Symptoms appear after 5 years
- Adult: Symptoms appear in adulthood
Why aren’t developing therapies ready to use as treatment yet?
Developing treatments takes time—up to 15 years—to ensure safety and effectiveness. Research must go through rigorous stages, including lab testing, animal trials, and human clinical trials. Regulatory agencies like the FDA and MHRA oversee this process, adding complexity. Additionally, Batten disease is a complex neurological disorder, making treatment development expensive and challenging.
What is the difference between NCL and CLN?
- NCL (Neuronal Ceroid Lipofuscinoses): A broad term for Batten disease.
- CLN (Ceroid Lipofuscinosis, Neuronal): Refers to specific gene mutations causing the disease.
Does gender or ethnicity affect Batten disease?
- Gender: Studies suggest that female patients may experience more severe symptoms and have a shorter lifespan, particularly in CLN2 cases.
- Ethnicity: While ethnicity itself does not influence the disease, some genetic mutations may be more common in specific ethnic groups.